News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SIMPSON TODD E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 14,746 shares
@ $0
Disposed/sold 1,106 shares
@ $193.8689, valued at
$214.4k
Disposed/sold 861 shares
@ $193.8689, valued at
$166.9k
Disposed/sold 1,540 shares
@ $193.8689, valued at
$298.6k
|
|
| 06/09/2023 |
4
| SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.79, valued at
$19.8k
|
|
| 04/04/2023 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Granted 1,395 shares
@ $0 |
|
| 03/10/2023 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 10,262 shares
@ $175.89, valued at
$1.8M
Sold 26,449 shares
@ $176.71, valued at
$4.7M
Sold 6,082 shares
@ $177.37, valued at
$1.1M
Exercised 42,793 options to buy
@ $45.3, valued at
$1.9M
|
|
| 02/28/2023 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 20,000 shares
@ $182.53, valued at
$3.7M
|
|
| 02/21/2023 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 39,946 shares
@ $160.001, valued at
$6.4M
Exercised 39,946 options to buy
@ $39.15, valued at
$1.6M
|
|
| 09/01/2022 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 2,122 shares
@ $154.4145, valued at
$327.7k
Sold 2,064 shares
@ $154.4145, valued at
$318.7k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 567 shares
@ $144.3186, valued at
$81.8k
|
|
| 12/22/2021 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 345 shares
@ $149.85, valued at
$51.7k
|
|
| 11/05/2021 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 40,232 shares
@ $185, valued at
$7.4M
Exercised 2,156 options to buy
@ $46.37, valued at
$100k
Exercised 40,232 options to buy
@ $44.09, valued at
$1.8M
|
|
| 11/02/2021 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 33,564 shares
@ $180.0001, valued at
$6M
Exercised 33,564 options to buy
@ $41.04, valued at
$1.4M
|
|
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 33,669 shares
@ $200, valued at
$6.7M
Exercised 1,104 options to buy
@ $45.3, valued at
$50k
Exercised 33,669 options to buy
@ $26.1, valued at
$878.8k
|
|
| 11/09/2020 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.|
Txns:
| Sold 7,509 shares
@ $180.368, valued at
$1.4M
|
|
| 09/02/2020 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 2,065 shares
@ $155.6942, valued at
$321.5k
Sold 2,122 shares
@ $155.6942, valued at
$330.4k
Sold 4,452 shares
@ $155.25, valued at
$691.2k
Sold 5,480 shares
@ $155.74, valued at
$853.5k
Sold 1,640 shares
@ $156.87, valued at
$257.3k
Sold 50 shares
@ $157.82, valued at
$7.9k
Sold 469 shares
@ $159.33, valued at
$74.7k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $12.84, valued at
$321k
|
|
| 05/06/2020 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 14,167 shares
@ $147.0005, valued at
$2.1M
Sold 13,500 shares
@ $162.45, valued at
$2.2M
Sold 12,167 shares
@ $163.36, valued at
$2M
Sold 1,200 shares
@ $164.1, valued at
$196.9k
Exercised 3,831 options to buy
@ $26.1, valued at
$100k
Exercised 2,554 options to buy
@ $39.15, valued at
$100k
Exercised 2,436 options to buy
@ $41.04, valued at
$100k
Exercised 2,268 options to buy
@ $44.09, valued at
$100k
Exercised 1,103 options to buy
@ $45.3, valued at
$50k
Exercised 14,167 options to buy
@ $12, valued at
$170k
Exercised 26,867 options to buy
@ $15.46, valued at
$415.4k
|
|
| 04/21/2020 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 2,389 shares
@ $0
Granted 1,439 shares
@ $0
Disposed/sold 570 shares
@ $139.9163, valued at
$79.8k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $2.82, valued at
$62k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| SIMPSON TODD E (See Remarks) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 21,288 shares
@ $0
Sold 2,092 shares
@ $70.7993, valued at
$148.1k
Granted 1,333 options to buy
@ $72.64, valued at
$96.8k
Granted 49,232 options to buy
@ $72.64, valued at
$3.6M
|
|
| 08/30/2019 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 5,909 shares
@ $73.2144, valued at
$432.6k
|
|
| 08/22/2019 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 12,500 shares
@ $80, valued at
$1M
|
|
| 04/09/2019 |
4
| SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Sold 2,063 shares
@ $78, valued at
$160.9k
Sold 10,437 shares
@ $78, valued at
$814.1k
|
|
|
|
|